Laurence Lasky - Net Worth and Insider Trading

Laurence Lasky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Laurence Lasky owns 3 companies in total, including Revolution Medicines Inc (RVMD) , OncoMed Pharmaceuticals Inc (OMED) , and eFFECTOR Therapeutics Inc (EFTR) .

Click here to see the complete history of Laurence Lasky’s form 4 insider trades.

Insider Ownership Summary of Laurence Lasky

Ticker	Comapny	Transaction Date	Type of Owner
RVMD	Revolution Medicines Inc	2020-02-12	director
OMED	OncoMed Pharmaceuticals Inc	2017-06-01	director
EFTR	eFFECTOR Therapeutics Inc	2021-08-25	director

Laurence Lasky Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Laurence Lasky Ownership Network

Ownership Network List of Laurence Lasky

No Data

Ownership Network Relation of Laurence Lasky

Laurence Lasky Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Laurence Lasky is the director of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Laurence Lasky made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Medicines Inc Insider Transactions

No Available Data

What does OncoMed Pharmaceuticals Inc do?

Who are the key executives at OncoMed Pharmaceuticals Inc?

Laurence Lasky is the director of OncoMed Pharmaceuticals Inc. Other key executives at OncoMed Pharmaceuticals Inc include See Remarks Sunil Patel , Chairman & CEO Paul J Hastings , and SVP & Chief Medical Officer Jakob Dupont .

OncoMed Pharmaceuticals Inc (OMED) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of OncoMed Pharmaceuticals Inc (OMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoMed Pharmaceuticals Inc (OMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

OncoMed Pharmaceuticals Inc (OMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

OncoMed Pharmaceuticals Inc Insider Transactions

No Available Data

What does eFFECTOR Therapeutics Inc do?

Who are the key executives at eFFECTOR Therapeutics Inc?

Laurence Lasky is the director of eFFECTOR Therapeutics Inc. Other key executives at eFFECTOR Therapeutics Inc include 10 percent owner Sr One Capital Fund I Aggregator Lp , director & 10 percent owner & Chief Executive Officer Christopher B Ehrlich , and Chief Business Officer Mayank Gandhi .

eFFECTOR Therapeutics Inc (EFTR) Insider Trades Summary

Over the past 18 months, Laurence Lasky made no insider transaction in eFFECTOR Therapeutics Inc (EFTR). Other recent insider transactions involving eFFECTOR Therapeutics Inc (EFTR) include a net sale of 609,163 shares made by Sr One Capital Fund I Aggregator Lp ,

In summary, during the past 3 months, insiders sold 0 shares of eFFECTOR Therapeutics Inc (EFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,367 shares of eFFECTOR Therapeutics Inc (EFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,367 shares.

eFFECTOR Therapeutics Inc (EFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

eFFECTOR Therapeutics Inc Insider Transactions

No Available Data

Laurence Lasky Mailing Address

Above is the net worth, insider trading, and ownership report for Laurence Lasky. You might contact Laurence Lasky via mailing address: C/o Column Group Lp, 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.